Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma - Wikidata - awgldk - TriplyDB

Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma

Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma

http://www.wikidata.org/entity/Q26740332

about

Signal Transducer and Activator of Transcription 3 for the Differentiation of Hepatocellular Carcinoma from Cirrhosis.Value of HCC-MELD Score in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation.

P2860

Q47153625-7CFF7643-0918-472A-AA99-9EED29A453E6 Q47574391-FFFF1EF3-EA48-484A-B8E4-79090EFB998B

P2860

Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma

http://www.wikidata.org/entity/Q26740332

description

2016 nî lūn-bûn

@nan

2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma

@ast

Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma

@en

Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma

@nl

type

label

Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma

@ast

Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma

@en

Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma

@nl

prefLabel

Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma

@ast

Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma

@en

Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma

@nl

P1433

Q26740332-2444C534-55FC-4831-8689-9EC71C53D885

P1476

Q26740332-9F40F0A2-2E8E-48AC-B834-3E1B3F4466F7

P2093

Q26740332-A2A43F36-FE24-4A80-9DDB-1DDBF3E8E1BA

Q26740332-B3ABB53B-F57C-4157-B9DA-F2E06D31F85D

Q26740332-F8956340-3006-40D3-A4FE-38D144E2FCF5

P2860

Q26740332-0218AD40-D14D-4D8C-B88A-A7A1F5453464

Q26740332-05BF235D-2E30-4008-A2B6-3AE77E77958D

Q26740332-15156998-8092-4269-BEA3-8E7674D6356F

Q26740332-1731816E-CE94-4F29-9515-3901CFD8F05E

Q26740332-1CDCAEBA-A779-48D7-9EA3-532C25B14C5E

Q26740332-28B515FE-7861-4189-B481-75F736588E62

Q26740332-355ED052-06A2-40D2-89D8-57784BD7E170

Q26740332-35B49A86-3E14-476C-B418-11486ED95452

Q26740332-384194EB-BC83-4032-ABB4-FDD1043CA190

Q26740332-39FDFFB4-E53F-4A62-AF7C-3CB5977A6C9E

P304

Q26740332-6DBFD0AB-BE3A-4248-B7DF-73020A9D2901

P31

Q26740332-9277CD2F-F312-4CEA-9E64-6AED6256B502

P356

Q26740332-09F3F8A9-AD18-440D-B914-0BC7DAB42E91

P407

Q26740332-E525849C-E09C-4C9D-8D4B-BC81A632CECF

P433

Q26740332-B04799FD-4848-4432-BD6D-24DE30907212

P478

Q26740332-66E3158D-E25A-4B03-BD95-0DBF4FB746AC

P50

Q26740332-5B3A20AD-A760-45F6-B55A-37062D603050

P577

Q26740332-8A6A6B1B-78F7-4E46-B23D-A53B8FB90FE0

P698

Q26740332-FB2368AD-64BB-485A-B1A0-DEAAF1D279FB

P921

Q26740332-0F966818-7A09-4142-8AE0-26F0578A8808

P932

Q26740332-59B17938-B2D1-4289-9167-FCA4F4BB6D2B

P356

P1433

World journal of hepatology

P1476

Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma

@en

P2093

Bertrand Suc

http://www.w3.org/2001/XMLSchema#string

Bérénice Charrière

http://www.w3.org/2001/XMLSchema#string

Charlotte Maulat

http://www.w3.org/2001/XMLSchema#string

P2860

Biomarkers for hepatocellular carcinoma

Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA

Management of hepatocellular carcinoma: An update

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis.

Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma.

Effect of pre- and post-treatment α-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study.

Combination of morphologic criteria and α-fetoprotein in selection of patients with hepatocellular carcinoma for liver transplantation minimizes the problem of posttransplant tumor recurrence.

P304

881-890

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4254/WJH.V8.I21.881

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Fabrice Muscari

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27478538

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation

P932

4958698

http://www.w3.org/2001/XMLSchema#string